By Professor David Lawson Morris

Journal articles

Morris DL, 2013, 'Peritonectomy HIPEC - Contemporary results, indications', Chinese Journal of Cancer Research, 25, pp. 373 - 374, http://dx.doi.org/10.3978/j.issn.1000-9604.2013.07.03

Pillai K; Pourgholami MH; Chua TC; Morris DL, 2013, 'MUC1 has prognostic significance in malignant peritoneal mesothelioma', International Journal of Biological Markers, 28, pp. 303 - 312, http://dx.doi.org/10.5301/JBM.5000038

Chan DL; Morris DL; Chua TC, 2013, 'Clinical efficacy and predictors of outcomes of repeat hepatectomy for recurrent hepatocellular carcinoma-A systematic review', Surgical Oncology, 22, http://dx.doi.org/10.1016/j.suronc.2013.02.009

Pillai K; Pourgholami MH; Chua TC; Morris DL, 2013, 'Oestrogen receptors are prognostic factors in malignant peritoneal mesothelioma', Journal of Cancer Research and Clinical Oncology, 139, pp. 987 - 994, http://dx.doi.org/10.1007/s00432-013-1408-2

Pillai K; Akhter J; Chua TC; Morris DL, 2013, 'Anticancer property of bromelain with therapeutic potential in malignant peritoneal mesothelioma', Cancer Investigation, 31, pp. 241 - 250, http://dx.doi.org/10.3109/07357907.2013.784777

Ataie-Kachoie P; Pourgholami MH; Morris DL, 2013, 'Inhibition of the IL-6 signaling pathway: A strategy to combat chronic inflammatory diseases and cancer', Cytokine and Growth Factor Reviews, 24, pp. 163 - 173, http://dx.doi.org/10.1016/j.cytogfr.2012.09.001

Pourgholami MH; Ataie-Kachoie P; Badar S; Morris DL, 2013, 'Minocycline inhibits malignant ascites of ovarian cancer through targeting multiple signaling pathways', Gynecologic Oncology, 129, pp. 113 - 119, http://dx.doi.org/10.1016/j.ygyno.2012.12.031

Koh JL; Liauw W; Chua Dr T; Morris DL, 2013, 'Carbohydrate antigen 19-9 (CA 19-9) is an independent prognostic indicator in pseudomyxoma peritonei post cytoreductive surgery and perioperative intraperitoneal chemotherapy', Journal of Gastrointestinal Oncology, 4, pp. 173 - 181, http://dx.doi.org/10.3978/j.issn.2078-6891.2012.062

Pillai K; Pourgholami MH; Chua TC; Morris DL, 2013, 'Does the expression of BCL2 have prognostic significance in malignant peritoneal mesothelioma?', AMERICAN JOURNAL OF CANCER RESEARCH, 3, pp. 312 - 322, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000331067800007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Saxena A; Chua TC; Fransi S; Liauw W; Morris DL, 2013, 'Effectiveness of early and aggressive administration of fresh frozen plasma to reduce massive blood transfusion during cytoreductive surgery', Journal of Gastrointestinal Oncology, 4, pp. 30 - 39, http://dx.doi.org/10.3978/j.issn.2078-6891.2012.046

Pillai K; Pourgholami MH; Chua TC; Morris DL, 2013, 'Ki67-BCL2 index in prognosis of malignant peritoneal mesothelioma', AMERICAN JOURNAL OF CANCER RESEARCH, 3, pp. 411 - 423, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000331069400007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ataie-Kachoie P; Badar S; Morris DL; Pourgholami MH, 2013, 'Minocycline targets the NF-κB nexus through suppression of TGF-β1-TAK1-IκB signaling in ovarian cancer', Molecular Cancer Research, 11, pp. 1279 - 1291, http://dx.doi.org/10.1158/1541-7786.MCR-13-0239

Saxena A; Morris DL, 2013, 'Mortality and morbidity after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis', Viszeralmedizin: Gastrointestinal Medicine and Surgery, 29, pp. 231 - 234, http://dx.doi.org/10.1159/000354133

Pillai K; Akhter J; Chua TC; Morris DL, 2013, 'A formulation for in situ lysis of mucin secreted in pseudomyxoma peritonei', International Journal of Cancer, http://dx.doi.org/10.1002/ijc.28380

Ehteda A; Galettis P; Pillai K; Morris DL, 2013, 'Combination of Albendazole and 2-Methoxyestradiol significantly improves the survival of HCT-116 tumor-bearing nude mice', BMC Cancer, 13, pp. Article number86, http://dx.doi.org/10.1186/1471-2407-13-86

Amini A; Ehteda A; Masoumi S; Moghaddam SM; Akhter J; Pillai K; Morris DL, 2013, 'Cytotoxic effects of bromelain in human gastrointestinal carcinoma cell lines (MKN45, KATO-III, HT29-5F12, and HT29-5M21)', OncoTargets and Therapy, 6, pp. 403 - 409, http://dx.doi.org/10.2147/OTT.S43072

Kim Y; Pourgholami MH; Morris DL; Lu H; Stenzel MH, 2013, 'Effect of shell-crosslinking of micelles on endocytosis and exocytosis: acceleration of exocytosis by crosslinking', Biomaterials Science, 1, pp. 265 - 275, http://dx.doi.org/10.1039/C2BM00096B

Mekkawy AH; Morris DL, 2013, 'Human sprouty1 suppresses urokinase receptor-stimulated cell migration and invasion.', ISRN Biochem, 2013, pp. 598251, http://dx.doi.org/10.1155/2013/598251

Moghaddam SM; Amini A; Wei AQ; Pourgholami MH; Morris DL, 2013, 'Initial report on differential expression of sprouty proteins 1 and 2 in human epithelial ovarian cancer cell lines', Journal of Oncology, 2012, pp. Article ID 373826, http://dx.doi.org/10.1155/2012/373826

Chan DL; Morris DL; Chua TC; Rao A, 2013, 'Intraperitoneal chemotherapy in ovarian cancer: A review of tolerance and efficacy', Cancer Management and Research, 4, pp. 413 - 422, http://dx.doi.org/10.2147/CMAR.S31070

Chua T; Quinn L; Zhao J; Morris D, 2013, 'Iterative Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Peritoneal Metastases', Annals of Oncology, 24, pp. iv29 - iv29, http://dx.doi.org/10.1093/annonc/mdt202.11

Ataie-kachoie P; Morris DL; Pourgholami MH, 2013, 'Minocycline Suppresses Interleukine-6, Its Receptor System and Signaling Pathways and Impairs Migration, Invasion and Adhesion Capacity of Ovarian Cancer Cells: In Vitro and In Vivo Studies', PLoS ONE, 8, pp. Article numbere60817, http://dx.doi.org/10.1371/journal.pone.0060817

Ung L; Chua TC; David L M, 2013, 'Peritoneal metastases of lower gastrointestinal tract origin:a comparative study of patient outcomes following cytoreduction and intraperitoneal chemotherapy.', J Cancer Res Clin Oncol, 139, pp. 1899 - 1908, http://dx.doi.org/10.1007/s00432-013-1507-0

Kirby R; Alzahrani N; Zhao J; Chua T; Liauw W; Morris D, 2013, 'Peritonectomy Results at St.George Hospital, Sydney, Australia at 677 Procedures', Annals of Oncology, 24, pp. iv79 - iv79, http://dx.doi.org/10.1093/annonc/mdt203.151

Bester L; Meteling B; Pocock NA; Saxena A; Chua TC; Morris DL, 2013, 'Radioembolisation with Yttrium-90 microspheres: An effective treatment modality for unresectable liver metastases.', Journal of Medical Imaging and Radiation Oncology, 57, pp. 72 - 80, http://dx.doi.org/10.1111/j.1754-9485.2012.02459.x

Alzahrani N; Chua T; Kirby R; Zhao J; Liauw W; Morris D, 2013, 'Synchrnous Peritonectyomy and Liver Resction in Colorectal Cancer', Annals of Oncology, 24, pp. iv68 - iv68, http://dx.doi.org/10.1093/annonc/mdt203.113

Pelz J; Chua T; Morris D; Esquivel J; Gasser M; Dörfer J; Germer CT; Kerscher A, 2012, 'Welche Rolle spielt die moderne systemische Kombinationschemotherapie in der Behandlung der Peritonealkarzinose eines kolorektalen Karzinoms?', Zeitschrift für Gastroenterologie, 50, http://dx.doi.org/10.1055/s-0032-1323928

Khan AB; Al-Suhaibani Y; Al-Mohaimeed K; Morris DL, 2012, 'Application of Advanced Multimodality Care to Pseudomyxoma Peritonei Patient: Report of First Patient Treated at a Tertiary Center', Indian Journal of Surgical Oncology, 1, pp. 270 - 273, http://dx.doi.org/10.1007/s13193-010-0036-4

Chua TC; Morris DL, 2012, 'Colorectal Liver Metastases with Extrahepatic Disease-A New Criteria for Oncologic Resection?', Journal of gastrointestinal cancer, 43, pp. 502 - 504, http://dx.doi.org/10.1007/s12029-011-9278-9

Kim Y; Liemmawal E; Pourgholami MH; Morris DL; Stenzel MH, 2012, 'Comparison of shell-cross-linked micelles with soft and glassy cores as a drug delivery vehicle for albendazole: Is there a difference in performance?', Macromolecules, 45, pp. 5451 - 5462, http://dx.doi.org/10.1021/ma300644v

Ehteda A; Galettis PT; Chu SLW; Pillai KR; Morris DL, 2012, 'Complexation of albendazole with hydroxypropyl-â-cyclodextrin significantly improves its pharmacokinetic profile, cell cytotoxicity and antitumor efficacy in nude mice', Anticancer Research, 32, pp. 3659 - 3666, http://dx.doi.org/

Mirarabshahii P; Pillai K; Chua TC; Pourgholami MH; Morris DL, 2012, 'Diffuse malignant peritoneal mesothelioma - An update on treatment', Cancer Treatment Reviews, 38, pp. 605 - 612, http://dx.doi.org/10.1016/j.ctrv.2011.10.006

Chua TC; Moran BJ; Sugarbaker PH; Levine EA; Glehen O; Gilly FN; Elias D; Baratti D; Deraco M; Sardi A; Morris DL; Peritoneal Surface Oncology Group International , 2012, 'Early and long-term outcome data on 2,298 patients with pseudomyxoma peritonei of appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.', J Clin Oncol, 30, pp. 532, http://www.ncbi.nlm.nih.gov/pubmed/27983354

Chua TC; Liauw W; Morris DL, 2012, 'Early recurrence of pseudomyxoma peritonei following treatment failure of cytoreductive surgery and perioperative intraperitoneal chemotherapy is indicative of a poor survival outcome', International Journal of Colorectal Disease, 27, pp. 381 - 389, http://dx.doi.org/10.1007/s00384-011-1303-8

Chua TC; Moran BJ; Sugarbaker PH; Levine E; Glehen O; Gilly FN; Baratti D; Deraco M; Elias D; Sardi A; Liauw WS; Yan TD; Barrios P; Gomez Portilla A; De hingh IH; Ceelen WP; Pelz JO; Piso P; Gonzalez-Moreno S; Van der speeten K; Morris DL, 2012, 'Early- and Long-Term Outcome Data of Patients With Pseudomyxoma Peritonei From Appendiceal Origin Treated by a Strategy of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.', Journal of Clinical Oncology, 30, pp. 2449 - 2456, http://dx.doi.org/10.1200/JCO.2011.39.7166

Kim Y; Pourgholami MH; Morris DL; Stenzel MH, 2012, 'Effect of cross-linking on the performance of micelles as drug delivery carriers: a cell uptake study.', Biomacromolecules, 13, pp. 814 - 825, http://dx.doi.org/10.1021/bm201730p

Chua TC; Morris DL, 2012, 'Exploring the role of resection of extrahepatic metastases from hepatocellular carcinoma', Surgical Oncology, 21, pp. 95 - 101, http://dx.doi.org/10.1016/j.suronc.2011.01.005

Chua TC; Saxena A; Liauw WS; Chu F; Morris DL, 2012, 'Hepatectomy and resection of concomitant extrahepatic disease for colorectal liver metastases - A systematic review.', European Journal of Cancer, 48, pp. 1757 - 1765, http://dx.doi.org/10.1016/j.ejca.2011.10.034

Chua TC; Saxena A; Chu F; Morris DL, 2012, 'Hepatic Resection for Transplantable Hepatocellular Carcinoma for Patients Within Milan and UCSF Criteria.', American Journal of Clinical Oncology - Cancer Clinical Trials, 35, pp. 141 - 145, http://dx.doi.org/10.1097/COC.0b013e318209ab7d

Cao CQ; Yan TD; Deraco M; Elias D; Glehen O; Levine E; Moran BJ; Morris DL; Chua TC; Piso P; Sugarbaker PH, 2012, 'Importance of gender in diffuse malignant peritoneal mesothelioma', Annals of Oncology, 23, pp. 1494 - 1498, http://dx.doi.org/10.1093/annonc/mdr477

Chua TC; Chong CH; Liauw WS; Zhao J; Morris DL, 2012, 'Inflammatory Markers in Blood and Serum Tumor Markers Predict Survival in Patients With Epithelial Appendiceal Neoplasms Undergoing Surgical Cytoreduction and Intraperitoneal Chemotherapy.', Annals of Surgery, 256, pp. 342 - 349, http://dx.doi.org/10.1097/SLA.0b013e3182602ad2

Saxena A; Chua TC; Zhao J; Morris DL, 2012, 'Liver-directed therapy for neuroendocrine neoplasm hepatic metastasis prolongs survival following progression after initial surgery', Journal of Surgical Oncology, 105, pp. 342 - 350, http://dx.doi.org/10.1002/jso.22114

Pourgholami MH; Mekkawy AH; Badar S; Morris DL, 2012, 'Minocycline inhibits growth of epithelial ovarian cancer', Gynecologic Oncology, 125, pp. 433 - 440, http://dx.doi.org/10.1016/j.ygyno.2012.01.006

Pillai K; Akhter J; Chua TC; Morris DL, 2012, 'Mucolysis by Ascorbic Acid and Hydrogen Peroxide on Compact Mucin Secreted in Pseudomyxoma Peritonei', Journal of Surgical Research, 174, pp. e69 - e73, http://dx.doi.org/10.1016/j.jss.2011.10.038

Klaver Y; Chua TC; De hingh I; Morris DL, 2012, 'Outcomes of elderly patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal cancer peritoneal carcinomatosis', Journal of Surgical Oncology, 105, pp. 113 - 118, http://dx.doi.org/10.1002/jso.22019

Chua T; Liauw W; Chu F; Morris D, 2012, 'P-0233 Summary Outcomes of Two-Stage Resection for Advanced Colorectal Liver Metastases', Annals of Oncology, 23, pp. iv96 - iv97, http://dx.doi.org/10.1016/s0923-7534(20)30160-5

Chua TC; Chong CH; Morris DL, 2012, 'Peritoneal Mesothelioma. Current Status and Future Directions', Surgical Oncology Clinics of North America, 21, pp. 635 - 643, http://dx.doi.org/10.1016/j.soc.2012.07.010

Bester L; Meteling B; Pocock NA; Pavlakis N; Chua TC; Saxena A; Morris DL, 2012, 'Radioembolization versus Standard Care of Hepatic Metastases: Comparative Retrospective Cohort Study of Survival Outcomes and Adverse Events in Salvage Patients', Journal of Vascular and Interventional Radiology, 23, pp. 96 - 105, http://dx.doi.org/10.1016/j.jvir.2011.09.028

Chua TC; Al-Alem I; Zhao J; Glenn DW; Liauw W; Morris DL, 2012, 'Radiofrequency ablation of concomitant and recurrent pulmonary metastases after surgery for colorectal liver metastases.', Annals of Surgical Oncology, 19, pp. 75 - 81, http://dx.doi.org/10.1245/s10434-011-1859-0

Chua TC; Morris DL, 2012, 'Resectable Colorectal Liver Metastases: Optimal Sequencing of Chemotherapy', Journal of gastrointestinal cancer, 43, pp. 496 - 498, http://dx.doi.org/10.1007/s12029-011-9272-2

Back to profile page